Total Payments
$4,697
2019 Payments
$533.49
Companies
29
Transactions
331
Medicare Patients
5,792
Medicare Billing
$482,857
Payment Breakdown by Category
Food & Beverage$4,638 (98.7%)
Education$58.85 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,638 | 326 | 98.7% |
| Education | $58.85 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $874.25 | 54 | $0 (2019) |
| PFIZER INC. | $486.53 | 38 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $437.79 | 34 | $0 (2019) |
| Lilly USA, LLC | $427.13 | 26 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $381.52 | 23 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $315.40 | 23 | $0 (2019) |
| Allergan Inc. | $286.96 | 22 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $273.19 | 18 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $264.11 | 17 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $193.00 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $533.49 | 45 | Novo Nordisk Inc ($156.83) |
| 2018 | $1,663 | 125 | Novo Nordisk Inc ($417.47) |
| 2017 | $2,500 | 161 | Lilly USA, LLC ($353.14) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 2 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2019 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/20/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
| 03/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: Diabetes | ||||||
| 03/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $0.08 | General |
| Category: Diabetes | ||||||
| 03/14/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Diabetes | ||||||
| 03/11/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/01/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 02/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: DIABETES | ||||||
| 02/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 02/13/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/05/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Diabetes | ||||||
| 01/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 01/23/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/09/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/08/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DIABETES | ||||||
| 12/19/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Diabetes | ||||||
| 12/14/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/13/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes | ||||||
| 12/07/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,531 | 2,120 | $447,517 | $120,805 |
| 2022 | 15 | 1,469 | 2,023 | $417,745 | $114,957 |
| 2021 | 16 | 1,396 | 1,923 | $338,406 | $111,582 |
| 2020 | 18 | 1,396 | 1,839 | $311,080 | $135,513 |
Total Patients
5,792
Total Services
7,905
Medicare Billing
$482,857
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 344 | 344 | $58,824 | $46,624 | 79.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 521 | 1,029 | $285,033 | $38,396 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 255 | 326 | $64,222 | $8,394 | 13.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 73 | 73 | $5,694 | $5,179 | 91.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 20 | $6,200 | $4,591 | 74.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $4,000 | $3,920 | 98.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $6,182 | $3,821 | 61.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 18 | $4,644 | $3,095 | 66.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 85 | $3,825 | $2,730 | 71.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,519 | $1,422 | 93.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,209 | $1,008 | 83.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 80 | 85 | $3,485 | $960.77 | 27.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,488 | $349.60 | 23.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 12 | $612.00 | $194.40 | 31.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 20 | $460.00 | $68.20 | 14.8% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 12 | 12 | $120.00 | $51.48 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 314 | 314 | $53,694 | $43,458 | 80.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 492 | 952 | $255,069 | $35,247 | 13.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 295 | 378 | $70,847 | $10,785 | 15.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 31 | 32 | $8,256 | $5,702 | 69.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 17 | 19 | $5,890 | $4,510 | 76.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $3,200 | $3,142 | 98.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,496 | $2,860 | 63.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 41 | $2,835 | $2,717 | 95.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 18 | 18 | $2,170 | $2,138 | 98.5% |
About Dr. Gregory Levickas, MD
Dr. Gregory Levickas, MD is a Internal Medicine healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891739744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Levickas, MD has received a total of $4,697 in payments from pharmaceutical and medical device companies, with $533.49 received in 2019. These payments were reported across 331 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,638).
As a Medicare-enrolled provider, Levickas has provided services to 5,792 Medicare beneficiaries, totaling 7,905 services with total Medicare billing of $482,857. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Catonsville, MD
- Active Since 06/15/2006
- Last Updated 04/28/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891739744
Products in Payments
- ENTRESTO (Drug) $381.52
- TRULICITY (Drug) $350.14
- FARXIGA (Drug) $315.40
- Ozempic (Drug) $310.62
- Tresiba (Drug) $244.56
- CHANTIX (Drug) $234.81
- TOUJEO (Drug) $221.36
- TRADJENTA (Drug) $216.11
- Victoza (Drug) $215.50
- JANUVIA (Drug) $197.51
- NUEDEXTA (Drug) $193.00
- Trintellix (Drug) $162.12
- ZOSTAVAX (Biological) $127.04
- BYSTOLIC (Drug) $100.47
- VRAYLAR (Drug) $97.57
- TRUMENBA (Biological) $91.80
- JARDIANCE (Drug) $91.74
- LINZESS (Drug) $69.59
- PREVNAR - 13 (Biological) $64.98
- Aimovig (Biological) $43.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Catonsville
Charles Moore, M.d, M.D
Internal Medicine — Payments: $10,315
Internal Medicine $10,315
Dr. Robert Ammlung, M.d, M.D
Internal Medicine — Payments: $8,640
Internal Medicine $8,640
Dr. Scott Poulton, M.d, M.D
Internal Medicine — Payments: $8,200
Internal Medicine $8,200
Dr. Benjamin Lee, M.d, M.D
Internal Medicine — Payments: $6,688
Internal Medicine $6,688
Dr. Debra Curtis, M.d, M.D
Internal Medicine — Payments: $6,181
Internal Medicine $6,181
Douglas Pinto, Md, MD
Internal Medicine — Payments: $5,781
Internal Medicine $5,781